Third Rock Ventures Ii, L.P. Myo Kardia Inc (MYOK) insider trading activity

Third Rock Ventures Ii, L.P. is > 10% Shareholder of MyoKardia Inc. Currently has a direct ownership of 885,104 shares of MYOK, which is worth approximately $199 Million. The most recent transaction as insider was on Mar 07, 2018, when has been sold 2,000,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 885K

0% 3M change

0% 12M change

Total Value Held $199 Million

Third Rock Ventures II, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 07 2018	SELL Other acquisition or disposition	-	2,000,000 Reduced 69.32%	885,104 Common Stock
Dec 06 2017	SELL Other acquisition or disposition	-	2,000,000 Reduced 40.94%	2,885,104 Common Stock
Sep 28 2017	SELL Other acquisition or disposition	-	2,000,000 Reduced 29.05%	4,885,104 Common Stock
Sep 26 2017	SELL Open market or private sale	$17,200,000 $43.0 p/Share	400,000 Reduced 5.49%	6,885,104 Common Stock
Sep 25 2017	SELL Open market or private sale	$8,660,200 $43.0 p/Share	201,400 Reduced 2.69%	7,285,104 Common Stock
Sep 11 2017	SELL Open market or private sale	$885,000 $44.25 p/Share	20,000 Reduced 25.76%	57,651 Common Stock
Sep 08 2017	SELL Open market or private sale	$8,392,125 $41.7 p/Share	201,250 Reduced 2.62%	7,486,504 Common Stock

Also insider at

ALNA

Allena Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

JNCE

Jounce Therapeutics, Inc. Healthcare

> 10% Shareholder

RVMD

Revolution Medicines, Inc. Healthcare

> 10% Shareholder

TRV